Innovation (IPIX) Stock Price, News & Analysis
Company Description
Innovation (OTC Link: IPIX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.6M.
IPIX has gained 200.0% over the past year. Shares last traded at $0.0030.
For FY2023, Innovation reported revenue of $0 with net income of -$3.2M.
This page collects what Stock Titan holds for IPIX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Innovation (IPIX) stock last closed at $0.0030. Over the past 12 months, the stock has gained 200.0%. At a market capitalization of $1.6M, IPIX is classified as a micro-cap stock with approximately 518.3M shares outstanding.
IPIX Rankings
Latest News
Innovation has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include fda approval, clinical trial. View all IPIX news →
SEC Filings
Financial Highlights
operating income reached -$3.1M, and net income was -$3.2M. The company generated -$2.1M in operating cash flow. With a current ratio of 0.33, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
IPIX Company Profile & Sector Positioning
Innovation (IPIX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing IPIX often look at related companies in the same sector, including Psybio Therapeau (PSYBF), Braxia Scientifi (BRAXF), BIORA THERAPEUTICS INC (BIOR), Yulong Eco-Matls Ltd (YECO), and Regen Biopharma (RGBPP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IPIX's relative position within its industry.